Trial intelligence / Profile preview

PRGF VS CGF in Management of Labial Dehiscence Around Immediate Implants

NCT05595772Completed

Sponsor
Minia University
Start
Feb 2022
Primary completion
Jul 2023
Countries
1
01

Overview

Randomised, open-label trial in Labial dehiscence comparing Group A (CGF) with Group B (PRGF) (2 arms). Primary endpoints: Bone Density at 9 months and Marginal Bone Level at 9 months. Started Feb 2022; status: completed.

02

Drugs

concentrated growth factorPRGF-Endoret
03

Conditions

Labial dehiscence

Beyond the preview

Go deeper on NCT05595772.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05595772.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call